Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Esketamine combined with dexmedetomidine
The First People's Hospital of Lianyungang
Dexmedetomidine
2 trials -
Exenatide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Flumatinib
The First People's Hospital of Lianyungang
Flumatinib
1 trial -
Folic Acid
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Fosinopril
The First People's Hospital of Lianyungang
Chronic Kidney Disease
1 trial -
Glucagon-like peptide-1 receptor agonist：Semaglutide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Glycopyrronium in Combination With Tropisetron
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
High-dose anrikefon
The First People's Hospital of Lianyungang
Laparoscopic Surgery
2 trials -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
Hydroxychloroquine Sulfate
The First People's Hospital of Lianyungang
Primary IgA Nephropathy
1 trial -
Hydroxychloroquine Sulfate 200 Mg Tablet
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
ICS/LABA
The First People's Hospital of Lianyungang
Asthma
1 trial -
IVC
The First People's Hospital of Lianyungang
Proliferative Diabetic Retinopathy
1 trial -
Icodextrin Peritoneal Dialysis Solution
The First People's Hospital of Lianyungang
Peritoneal Dialysis
1 trial -
Individual ATG
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
Infliximab
The First People's Hospital of Lianyungang
Crohn's Diseases
1 trial -
Insulin
The First People's Hospital of Lianyungang
Brain Injuries
1 trial -
Insulin
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Intranasal dexmedetomidine-esketamine
The First People's Hospital of Lianyungang
Adenotonsillectomy
1 trial -
Intravenous Immunoglobulins, Human
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
Intravenous thrombolysis + edaravone
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Irinotecan liposomes combined with cisplatin/carboplatin
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
1 trial -
Ixazomib
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources